Innovating Works

IM2PACT

Financiado
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERS...
2.18M€ | Lider
NOVARTIS FARMACEUTICA
646.21K€ | Participante
UNIMORE
67.57K€ | Participante
JANSSEN PHARMACEUTICA NV
1.10M€ | Participante
CARDIFF UNIVERSITY
326.11K€ | Participante
H. LUNDBECK AS
600.00K€ | Participante
UMC-Mainz
288.66K€ | Participante
SARD
1.50M€ | Participante
Novo Nordisk
714.02K€ | Participante
OU
232.28K€ | Participante
PHARMACOIDEA KFT.
300.06K€ | Participante
UNIVDUN
354.01K€ | Participante
ARTEMIS Bio-Support
290.38K€ | Participante
UHEI
290.19K€ | Participante
UCPH
602.20K€ | Participante
UU
1.11M€ | Participante
NEUWAY PHARMA
112.50K€ | Participante
STICHTING AMSTERDAM UMC
290.44K€ | Participante
MIMETAS
251.81K€ | Participante
AIT
403.69K€ | Participante
KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVER...
293.72K€ | Participante
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER
290.31K€ | Participante
USFD
249.31K€ | Participante
FUJIFILM CELLULAR DYNAMICS INC
NOVARTIS
1.75M€ | Participante
Leiden University Medical Center
297.50K€ | Participante
MEDIZINISCHE UNIVERSITAET WIEN
208.60K€ | Participante
AU
553.97K€ | Participante
Pfizer RD UK Limited
796.12K€ | Participante
FCDI
1.90M€ | Participante